Hetlioz Pill
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Tasimelteon (Hetlioz®) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non…
Tasimelteon (Hetlioz®), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be…